Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the next ...
Trinity Biotech (NASDAQ:TRIB) Cut to Sell at StockNews.com
StockNews.com cut shares of Trinity Biotech (NASDAQ:TRIB – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Trinity Biotech Stock Up 1.6 % Shares of TRIB ...
Nasdaq14d
Trinity Biotech Secures Additional $4 Million in Debt Financing to Advance Continuous Glucose Monitoring Technology and Transformation Plan
market acceptance of its products, and impacts related to COVID-19, which could hinder its growth prospects. More information is available on Trinity Biotech's official website: www.trinitybiotech ...
Yahoo Finance7d
Trinity Biotech plc (TRIB)
Mr. Donohue brings more than 25 years of experience in the sales and marketing of healthcare products. John Gillard, President and Chief Executive Officer of Trinity Biotech, said, “We are resolute ...
HIV Diagnostics Market worth $5.31 billion by 2030
The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...
Morningstar14d
Trinity Biotech PLC ADR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.